220
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Preparation and characterisation of gastroretentive alginate beads for targeting H. pylori

&
Pages 58-67 | Received 21 Nov 2012, Accepted 09 May 2013, Published online: 24 Jun 2013

References

  • Abid Y, Gustafsson L, Ericsson O, Hellgren U. 1995. Metronidazole. Handbook of drugs for tropical parasitic infections, 2nd edn. London: Taylor & Francis
  • Adebisi A, Conway BR. Gastroretentive microparticles for drug delivery applications. J Microencapsul, 2011;28:689–708
  • Anilkumar SJ. 2008. Gastro retentive drug delivery systems: An overview. Pharminfo.net [Online], 6. Accessed 12 October 2010
  • Bai YX, Li YF. Preparation and characterization of crosslinked porous cellulose beads. Carbohydr Polym, 2006;64:402–7
  • Bajpai SK, Tankhiwale R. Investigation of water uptake behavior and stability of calcium alginate/chitosan bi-polymeric beads: Part-1. React Funct Polym, 2006;66:645–58
  • Batchelor H, Conway B, Williams RO. 2007. Targeting the infections within the gastro-intestinal tract. In: Williams RO, Taft DR, McConville JT, eds. Advanced drug formulation design to optimize therapeutic outcomes (Drugs and the Pharmaceutical Sciences). New York: Informa Healthcare
  • Bazzoli F, Bianchi Porro G, Maconi G, Molteni M, Pozzato P, Zagari RM. Treatment of Helicobacter pylori infection. indications and regimens: An update. Digest Liver Dis, 2002;34:70–83
  • Castro M, Romero C, de Castro A, Vargas J, Medina E, Millan R, Brenes M. Assessment of Helicobacter pylori eradication by virgin olive oil. Helicobacter, 2012;17:305–11
  • Desai SJ, Singh P, Simonelli AP, Higuchi WI. Investigation of factors influencing release of solid drug dispersed in inert matrices. 3. Quantitative studies involving the polyethylene plastic matrix. J Pharm Sci, 1966;55:1230–4
  • Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev, 1997;10:720–41
  • Dupuy B, Arien A, Perrot Minnot A. FT-IR of membranes made with alginate/polylysine complexes. Variations with the mannuronic or guluronic content of the polysaccharides. Artif Cells Blood Substit Immobil Biotechnol, 1994;22:71–82
  • El-Kamel AH, Al-Gohary OM, Hosny EA. Alginate-diltiazem hydrochloride beads: Optimization of formulation factors, in vitro and in vivo availability. J Microencapsul, 2003;20:211–25
  • Erah PO, Goddard AF, Barrett DA, Shaw PN, Spiller RC. The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: Relevance to the treatment of Helicobacter pylori infection. J Antimicrob Chemother, 1997;39:5–12
  • Ernst PB, Gold BD. The disease spectrum of Helicobacter pylori: The immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol, 2000;54:615–40
  • Fennema OR. 1975. Principles of food science, Part II: Physical principles of food preservation. New York: Marcel Dekker, Inc
  • Gal A, Nussinovitch A. Hydrocolloid carriers with filler inclusion for diltiazem hydrochloride release. J Pharm Sci, 2007;96:168–78
  • Georgopoulos SD, Papastergiou V, Karatapanis S. Helicobacter pylori eradication therapies in the era of increasing antibiotic resistance: A paradigm shift to improved efficacy. Gastroenterol Res Pract, 2012;2012:9
  • Higuchi T. Mechanism of sustained-action medication. theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci, 1963;52:1145–9
  • Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation. Indus Eng Chem, 1931;23:923–31
  • Iijima K, Sekine H, Koike T, Imatani A, Ohara S, Shimosegawa T. Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria. Aliment Pharmacol Ther, 2004;19:1181–8
  • Ishak RA, Awad GA, Mortada ND, Nour SA. Preparation, in vitro and in vivo evaluation of stomach-specific metronidazole-loaded alginate beads as local anti-Helicobacter pylori therapy. J Control Release, 2007;119:207–14
  • Kawahara Y, Mizuno M, Yoshino T, Yokota K, Oguma K, Okada H, Fujiki S, Shiratori Y. HLA-DQA1*0103-DQB1*0601 haplotype and Helicobacter pylori-positive gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol, 2005;3:865–8
  • Kim C-K, Lee E-J. The controlled release of blue dextran from alginate beads. Int J Pharm, 1992;79:11–19
  • Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm, 1983;15:25–35
  • Lehmann FS, Terracciano L, Carena I, Baeriswyl C, Drewe J, Tornillo L, De Libero G, Beglinger C. In situ correlation of cytokine secretion and apoptosis in Helicobacter pylori-associated gastritis. Am J Physiol Gastrointest Liver Physiol, 2002;283:G481–8
  • Mai TTT, Ha PT, Pham HN, Le TTH, Pham HL, Phan TBH, Tran DL, Nguyen XP. Chitosan and O-carboxymethyl chitosan modified Fe 3 O 4 for hyperthermic treatment. Adv Nat Sci Nanosci Nanotechnol, 2012;3:015006
  • Malfertheiner P, Megraud F, O’Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: The Maastricht III Consensus Report. Gut, 2007;56:772–81
  • Murata Y, Sasaki N, Miyamoto E, Kawashima S. Use of floating alginate gel beads for stomach-specific drug delivery. Eur J Pharm Biopharm, 2000;50:221–6
  • Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet, 1997;349:1269–76
  • Najib N, Suleiman MS. The kinetics of drug release from ethylcellulose solid dispersions. Drug Dev Ind Pharm, 1985;11:2169–81
  • Nassar EJ, Ciuffi KJ, Ribeiro SJL, Messaddeq Y. Europium incorporated in silica matrix obtained by sol-gel: Luminescent materials. Mater Res, 2003;6:557–62
  • Østberg T, Lund EM, Graffner C. Calcium alginate matrices for oral multiple unit administration: IV. Release characteristics in different media. Int J Pharm, 1994;112:241–8
  • Pasparakis G, Bouropoulos N. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads. Int J Pharm, 2006;323:34–42
  • Patel YL, Sher P, Pawar AP. The effect of drug concentration and curing time on processing and properties of calcium alginate beads containing metronidazole by response surface methodology. AAPS PharmSciTech, 2006;7:86
  • Peeush S, Kapil K, Manisha SA. Evaluation of acyclovir loaded oil entrapped calcium alginate beads prepared by ionotropic gelation method. Int J ChemTech Res, 2010;2:2076–85
  • Pereira L, Sousa A, Coelho H, Amado AM, Ribeiro-Claro PJA. Use of FTIR, FT-Raman and 13C-NMR spectroscopy for identification of some seaweed phycocolloids. Biomol Eng, 2003;20:223–8
  • Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med, 1991;324:1043–8
  • Rajinikanth PS, Mishra B. Floating in situ gelling system for stomach site-specific delivery of clarithromycin to eradicate H. pylori. J Control Release, 2008;125:33–41
  • Rastogi R, Sultana Y, Aqil M, Ali A, Kumar S, Chuttani K, Mishra AK. Alginate microspheres of isoniazid for oral sustained drug delivery. Int J Pharm, 2007;334:71–7
  • Reynolds JF. 1993. Metronidazole. In: Martindale W, ed. The extra pharmacopoeia. London: Pharmaceutical Press (UK)
  • Romero C, Medina E, Vargas J, Brenes M, De Castro A. In vitro activity of olive oil polyphenols against Helicobacter pylori. J Agric Food Chem, 2007;55:680–6
  • Rothenbacher D, Brenner H. Burden of Helicobacter pylori and H. pylori-related diseases in developed countries: Recent developments and future implications. Microbes Infect, 2003;5:693–703
  • Smrdel P, Bogataj M, Zega A, Planinsek O, Mrhar A. Shape optimization and characterization of polysaccharide beads prepared by ionotropic gelation. J Microencapsul, 2008;25:90–105
  • Stops F, Fell JT, Collett JH, Martini LG. Floating dosage forms to prolong gastro-retention – the characterisation of calcium alginate beads. Int J Pharm, 2008;350:301–11
  • Suerbaum S, Michetti P. Helicobacter pylori Infection. N Engl J Med, 2002;347:1175–86
  • Suzuki H, Ishii H. Role of apoptosis in Helicobacter pylori-associated gastric mucosal injury. J Gastroenterol Hepatol, 2000;15:D46–54

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.